Advertisement
Screener

Nuvation Bio Inc. (NUVB) Auditor

Nuvation Bio Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-02: Fiscal year end 2025-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location New York, NY.
  • 2025-03-06: Fiscal year end 2024-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location New York, NY.
  • 2024-04-26: Fiscal year end 2023-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location Short Hills, NJ.
  • 2024-02-29: Fiscal year end 2023-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location Short Hills, NJ.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-022025-12-31KPMG LLP185New York, NYNo
2025-03-062024-12-31KPMG LLP185New York, NYNo
2024-04-262023-12-31KPMG LLP185Short Hills, NJNo
2024-02-292023-12-31KPMG LLP185Short Hills, NJNo
2023-03-152022-12-31KPMG LLP185Short Hills, New JerseyNo
2022-02-282021-12-31KPMG LLP185Short Hills, New JerseyYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Biohaven Ltd. (BHVN)United States$1.990B-3.83
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Generate Biomedicines, Inc. (GENB)United States$2.052B
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B